Elevance Health (ELV) FY2025 10-K Annual Report
Elevance Health (ELV) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 6, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
Elevance Health FY2025 10-K Analysis
Business Overview
- • Core business model: Health benefits and insurance services built significantly through mergers, acquisitions, joint ventures, and strategic alliances
- • Emphasis on risks related to integration and liabilities from recent and future business combinations impacting financials and operations
Management Discussion & Analysis
- • Revenue details and YoY change not disclosed in provided text
- • Operating gain and margin defined but no actual % figures or changes provided
Risk Factors
- • Risk adjustment audits by CMS and HHS OIG awaiting finalization, with potential retroactive payment adjustments impacting financial results
- • Concentration in states like California, NY, Texas, exposed to regional economic downturns affecting enrollment and revenues
Elevance Health FY2025 Key Financial MetricsXBRL
Revenue
$199.1B
▲ +12.5% YoY
Net Income
$5.7B
▼ -5.3% YoY
Operating Margin
3.6%
▼ -83bp YoY
Net Margin
2.8%
▼ -53bp YoY
ROE
12.9%
▼ -157bp YoY
Total Assets
$121.5B
▲ +3.9% YoY
EPS (Diluted)
$25.21
▼ -1.8% YoY
Operating Cash Flow
$4.3B
▼ -26.1% YoY
Source: XBRL data from Elevance Health FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on Elevance Health
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.